Food-sourced mi­cro­bio­me drugs get $101M megaround for Flag­ship's Kalei­do

Min­ing food for safer sources of chem­istry, mi­cro­bio­me start­up Kalei­do has closed a $101 mil­lion megaround to push its pipeline through the clin­ic.

The com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.